Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 619.85 INR 0.6%
Market Cap: 266.9B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+24%
Revenue
Forecast
+33%
Operating Income
Forecast
+80%
Net Income
Forecast
+63%

Wall Street
Price Targets

GLAND Price Targets Summary
Gland Pharma Ltd

Wall Street analysts forecast GLAND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAND is 1 651.99 INR with a low forecast of 1 363.5 INR and a high forecast of 2 121 INR.

GLAND Lowest Forecast
Wall Street Target
1 363.5 INR
16% Downside
GLAND Average Forecast
Wall Street Target
1 651.99 INR
2% Upside
GLAND Highest Forecast
Wall Street Target
2 121 INR
31% Upside
Lowest
Price Target
1 363.5 INR
16% Downside
Average
Price Target
1 651.99 INR
2% Upside
Highest
Price Target
2 121 INR
31% Upside
Gland Pharma Ltd Competitors:
Price Targets
IPN
Ipsen SA
17% Upside
AVDL
Avadel Pharmaceuticals PLC
112% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
48% Upside
600216
Zhejiang Medicine Co Ltd
37% Upside
IPN
Ipsen SA
17% Upside
AVDL
Avadel Pharmaceuticals PLC
112% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
48% Upside
600216
Zhejiang Medicine Co Ltd
37% Upside
PBH
Prestige Consumer Healthcare Inc
9% Upside
ANIP
ANI Pharmaceuticals Inc
25% Upside
P
PPLPHARMA
Piramal Pharma Ltd
35% Upside
A
AETHER
Aether Industries Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Gland Pharma Ltd

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's revenue is 23%. The projected CAGR for the next 3 years is 9%.

23%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Gland Pharma Ltd

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's operating income is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Gland Pharma Ltd

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's net income is 11%. The projected CAGR for the next 3 years is 16%.

11%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
GLAND intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLAND stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLAND stock valuation using valuation multiples.
Wall Street Estimates
GLAND price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLAND stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLAND's stock price target?
Price Target
1 651.99 INR

According to Wall Street analysts, the average 1-year price target for GLAND is 1 651.99 INR with a low forecast of 1 363.5 INR and a high forecast of 2 121 INR.

What is Gland Pharma Ltd's Revenue forecast?
Projected CAGR
9%

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's revenue is 23%. The projected CAGR for the next 3 years is 9%.

What is Gland Pharma Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's operating income is 10%. The projected CAGR for the next 3 years is 15%.

What is Gland Pharma Ltd's Net Income forecast?
Projected CAGR
16%

For the last 5 years the compound annual growth rate for Gland Pharma Ltd's net income is 11%. The projected CAGR for the next 3 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.